Changes in antimicrobial resistance and outcomes of health care-associated infections

Eur J Clin Microbiol Infect Dis. 2021 Aug;40(8):1737-1742. doi: 10.1007/s10096-020-04140-y. Epub 2021 Feb 14.

Abstract

To describe the change in the epidemiology of health care-associated infections (HAI), resistance and predictors of fatality we conducted a nationwide study in 24 hospitals between 2015 and 2018. The 30-day fatality rate was 22% in 2015 and increased to 25% in 2018. In BSI, a significant increasing trend was observed for Candida and Enterococcus. The highest rate of 30-day fatality was detected among the patients with pneumonia (32%). In pneumonia, Pseudomonas infections increased in 2018. Colistin resistance increased and significantly associated with 30-day fatality in Pseudomonas infections. Among S. aureus methicillin, resistance increased from 31 to 41%.

Keywords: Blood stream infections; Colistin resistance; Health care; associated infections.

Publication types

  • Multicenter Study

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Antifungal Agents / pharmacology*
  • Bacteremia / microbiology
  • Bacteria / drug effects
  • Bacterial Infections / drug therapy*
  • Bacterial Infections / microbiology
  • Candida / drug effects
  • Cross Infection / drug therapy*
  • Cross Infection / microbiology*
  • Drug Resistance, Bacterial
  • Fungemia / microbiology
  • Humans
  • Mycoses / drug therapy
  • Mycoses / microbiology*
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents